A detailed history of Us Bancorp \De\ transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 563 shares of MDGL stock, worth $122,171. This represents 0.0% of its overall portfolio holdings.

Number of Shares
563
Previous 792 28.91%
Holding current value
$122,171
Previous $221,000 46.15%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$212.22 - $292.96 $48,598 - $67,087
-229 Reduced 28.91%
563 $119,000
Q2 2024

Aug 06, 2024

BUY
$193.33 - $291.99 $11,213 - $16,935
58 Added 7.9%
792 $221,000
Q1 2024

May 07, 2024

SELL
$171.37 - $283.23 $112,932 - $186,648
-659 Reduced 47.31%
734 $196,000
Q4 2023

Feb 09, 2024

SELL
$120.4 - $237.13 $102,821 - $202,509
-854 Reduced 38.01%
1,393 $322,000
Q3 2023

Nov 03, 2023

SELL
$146.04 - $225.78 $24,388 - $37,705
-167 Reduced 6.92%
2,247 $328,000
Q2 2023

Aug 09, 2023

BUY
$203.88 - $312.0 $100,512 - $153,816
493 Added 25.66%
2,414 $557,000
Q1 2023

May 09, 2023

BUY
$231.06 - $307.08 $328,336 - $436,360
1,421 Added 284.2%
1,921 $465,000
Q4 2022

Feb 13, 2023

BUY
$58.39 - $296.54 $8,291 - $42,108
142 Added 39.66%
500 $145,000
Q3 2022

Oct 27, 2022

BUY
$60.57 - $79.51 $12,235 - $16,061
202 Added 129.49%
358 $23,000
Q2 2022

Aug 01, 2022

SELL
$58.04 - $100.2 $11,259 - $19,438
-194 Reduced 55.43%
156 $11,000
Q1 2022

May 11, 2022

BUY
$55.89 - $101.89 $2,067 - $3,769
37 Added 11.82%
350 $34,000
Q4 2021

Feb 11, 2022

BUY
$72.34 - $95.09 $20,761 - $27,290
287 Added 1103.85%
313 $27,000
Q3 2021

Nov 10, 2021

SELL
$78.35 - $105.02 $6,189 - $8,296
-79 Reduced 75.24%
26 $2,000
Q2 2021

Aug 05, 2021

SELL
$97.2 - $137.59 $777 - $1,100
-8 Reduced 7.08%
105 $10,000
Q1 2021

Apr 28, 2021

BUY
$108.54 - $125.2 $8,574 - $9,890
79 Added 232.35%
113 $13,000
Q4 2020

Feb 04, 2021

BUY
$110.06 - $133.7 $2,861 - $3,476
26 Added 325.0%
34 $4,000
Q2 2020

Aug 07, 2020

SELL
$60.13 - $125.71 $13,709 - $28,661
-228 Reduced 96.61%
8 $1,000
Q1 2020

May 13, 2020

BUY
$66.76 - $93.49 $534 - $747
8 Added 3.51%
236 $16,000
Q4 2019

Feb 04, 2020

SELL
$84.28 - $118.5 $2,612 - $3,673
-31 Reduced 11.97%
228 $21,000
Q3 2019

Nov 08, 2019

BUY
$84.4 - $106.53 $19,243 - $24,288
228 Added 735.48%
259 $22,000
Q4 2018

Feb 13, 2019

SELL
$94.77 - $215.54 $6,349 - $14,441
-67 Reduced 68.37%
31 $3,000
Q3 2018

Nov 01, 2018

BUY
$207.3 - $300.31 $9,743 - $14,114
47 Added 92.16%
98 $21,000
Q2 2018

Aug 08, 2018

BUY
$101.55 - $313.9 $5,179 - $16,008
51 New
51 $14,000

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $3.71B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Us Bancorp \De\ Portfolio

Follow Us Bancorp \De\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.